GOURI PCL

GOURI is a revolutionary injectable treatment developed in Korea, recognized as the world’s first 100% liquid polycaprolactone (PCL) formulation. It serves as a collagen biostimulator, designed to combat the signs of aging by enhancing the skin’s natural collagen production. As we age, our skin loses elasticity and firmness due to a decrease in collagen synthesis. GOURI addresses this issue by promoting neocollagenesis, which helps restore youthful skin characteristics.

Introducing GOURI: A New Era in Facial Rejuvenation with Patented Liquid Polycaprolactone Technology

GOURI is an innovative skincare solution brought to you by DEXLEVO. This cutting-edge product leverages a patented technology that initiates the natural regeneration of collagen in your skin, all without the need for microparticles. As the first liquid-type PCL (polycaprolactone) injectable on the market, GOURI is at the forefront of non-surgical facial rejuvenation. By promoting collagenesis across your entire face, GOURI addresses the skin-aging process, reigniting your skin's vitality.

The Science Behind GOURI

GOURI harnesses the power of PCL, a high molecular material with remarkable regenerative properties. It typically takes 6-12 months for the body to degrade PCL, providing you with long-lasting benefits. This innovative solution initiates the synthesis of new collagen, tackling a common issue in aging skin where collagen levels diminish. However, the time required for neocollagenesis to take effect may vary from person to person. While some individuals experience visible results within 1-2 weeks, others might require more time.

An Evolving Solution

GOURI isn't just limited to facial treatments; it's the first of its kind in the world of fully liquid PCL injectables. Unlike other high polymer products that aren't fully liquid, GOURI is designed to spread evenly across your entire face. Traditional products often consist of high polymer material powder mixed with liquid saline or CMC gel, limiting their coverage and increasing the risk of complications. These traditional products also run the risk of localized effects and potential hypercorrection if too much material is injected. GOURI, as a completely liquid PCL injectable, provides uniform facial coverage, significantly reducing these concerns.

The PCL Difference

GOURI boasts a 21% PCL concentration, setting it apart from other products. It has successfully completed rigorous Phase-1 and Phase-2 clinical trials, involving over 200 individuals. Our recommendations for optimal results include three sessions at four-week intervals. After the third session, additional sessions may be applied at intervals of 3-6 months to maintain collagen levels.

Safe, Effective, and Versatile

While GOURI is primarily recommended for facial treatments, we're actively collecting clinical data on its potential use in other areas, such as hands and neck injections. This pioneering product comes with the assurance of both safety and efficiency, making it a game-changer in the world of facial rejuvenation.